Letter to ACIPC17 delegates

A letter sent today to all 308 delegates to the 2017 Australasian Conference on Infection Prevention and Control.

Dear Delegate,

I wish to draw your attention to the presence of Hygiene Solutions Ltd at ACIPC17. This UK company presents a serious threat to healthcare providers in Australia and New Zealand . Extensive evidence from both published papers and from disclosures by former employees of the business has revealed numerous fraudulent practices and reckless and irresponsible actions by this company. One well documented example is a very substantial and clearly correlated step increase in C. difficile infections in the University College London Hospitals on the implementation of the Deprox system, followed by an equally clear decrease when this system was abandoned 2  and a half years later. Approximately 70 additional cases over baseline occurred over the 29 months of Deprox operation. See: https://www.linkedin.com/pulse/freedom-information-request-reveals-exact-c-richard-marsh/

In brief, the history of these issues is as follows:

In response to insoluble technical problems with residual H2O2 vapour, the system manufacturer, Specialist Hygiene Solutions Ltd, secretly and drastically cut the disinfectant vapour concentration settings on the entire fleet of almost 200 systems, leaving the process almost entirely ineffective against the deadly HCAI pathogens it was claimed to eliminate. See:

https://deproxfraud.info/2017/03/13/leaked-emails-prove-test-cheating-bodily-harm-and-massive-fraud/

Thus not only were tens of thousands of patients needlessly put at risk of debilitating and possibly fatal infections, but the health services of the UK,  Australia and New Zealand were defrauded of over £20,000,000.

Further to this, the Deproxin solution contains silver nitrate, which is forbidden in the EU for fogging applications on account of its toxicity to lung tissue and mucous membranes. Several Deprox operators have suffered chronic respiratory illness as a result of being exposed to the residual fog after a room has been treated. These persons are actively seeking legal compensation for these injuries.

See: https://deproxfraud.info/2017/11/07/2-more-deprox-operators-hit-with-throat-and-lung-damage/

The UK market is now largely aware of the dangerous and fraudulent nature of Hygiene Solutions Ltd, which has crippled their sales prospects in that area – hence their presence at ACIPC17 in an attempt to open up the Australasian market.

My simple request is that any healthcare institution contemplating doing business with Hygiene Solutions Ltd should thoroughly research the health and safety, and the germicidal efficacy of the products offered.  Independent confirmation should be sought, as the directors of the company have no hesitation about fabricating evidence.

No less than 39 examples of these fabrications can be found here:

https://deproxfraud.info/deprox-fraud/

The Health and Safety Executive is leading an investigation in to Hygiene Solutions Ltd in the UK.  The officer coordinating the operation is Mr Martin Ball;

Martin Ball | HM Inspector of Health and Safety

CRD Compliance Team

Health & Safety Executive Chemicals Regulation Division

5S.1 Redgrave Court, Merton Road, Bootle, Merseyside, L20 7HS.

Tel: 0151 951 3512

martin.ball@hse.gov.uk

Summary of issues

  • The process is only capable of a small fraction of the claimed disinfection efficacy.
  • Rooms and equipment cleaned with Deprox remain dangerously contaminated with pathogens, and are a serious and potentially lethal threat to patients.
  • Residual chemicals of H2O2, AgNO3 and PbO are way in excess of legal limits and several operators have suffered permanent respiratory damage.
  • The fraud is accomplished by a complex and sophisticated web of misinformation, outright lies, rigged tests, and claiming test results from competitor’s machines as their own.
  • Healthcare providers in the UK, AU and NZ are being defrauded of tens of millions of pounds.

Sincerely,

Richard Marsh

http://www.deproxfraud.info

Rick fentiman

 

Response to my letter to #ACIPC17 Delegates, from an administrator within the North Sydney Local Health District

#acipc17

 

 

Hygiene Solutions posts fake email addresses at ACIPC17

Hygiene Solutions has two new e-publications for ACIPC17, these are in the Sponsor e-satchel section on the ACIPC17 app. ( https://guidebook.com/guide/102693/poi/8908501/ )

All but one of the website addresses given on these documents is fake:

www.hygienesolutionsau.com

www.hygienesolutionsnz.com

www.hygienesolutionsus.com

Only the UK website actually exists:

www.hygienesolutionsuk.com

wrong address

 

Catalyst hoax exposed!

Sources close to Hygiene Solutions Ltd.  have revealed that the 45 minute deactivation phase of the Deprox cycle, which is claimed to bring the hydrogen peroxide level down to 1ppm, was recently doubled to 90 minutes.

This is a tacit admission that the catalytic deactivation units, added in great haste last year are hopelessly inadequate.

The change pushes the vaunted Deprox cycle time to over 3 hours – this is not competitive in the face of the Bioquell BQ-50, which for a typical side ward with ensuite (50m3) has a cycle time of just 1 hour 20 minutes. Given the cost of a hospital bed in the UK is about £400/day, this difference is very significant.

When Deprox was introduced, it had no catalyst whatever, and the hydrogen peroxide concentration when the room was re-entered was typically around 10ppm – ten times the legal limit.

As increasing evidence accumulated that Deprox operators were suffering serious respiratory damage, Hygiene Solutions endeavored to conceal the problem by turning down the amount of H2O2 the machines emitted. All Deprox machines were turned down to just 1/6th of the original H2O2 aerial concentration. This indeed left the concentration below 1ppm on re-entry, but of course it didn’t decontaminate the hospital room.

In early 2016, Richard Marsh who had worked briefly as a consultant for Hygiene Solutions Ltd, attempted to warn the NHS and the HSE of this highly  dangerous practice, which was leaving 1000s of hospital rooms contaminated with C. difficile and MRSA across the UK, Australia and New Zealand.

Hygiene Solutions directors Rick Fentiman and Mark Fentiman of course categorically denied the claim, but hastily recalled all the Deprox units and retrofitted a crude catalyst, consisting of a commercial bathroom extract fan and a carbon palladium filter. According to a former employee, the catalyst was attached with cable ties and insulating tape.

These catalysts worked well when fresh, but quickly became hopelessly contaminated with dust and silver nitrate  – their efficiency dropping to zero within a few dozen cycles.

Hygiene Solutions, ever innovative, came up with a new strategy. Where customers were using hydrogen peroxide meters to check the rooms before re-entry, the units would be turned down to the low 1/6th of nominal concentration. Where the customers were NOT checking before re-entry, they would leave the machines at the higher level. If one of these customers should complain of respiratory problems on re-entry, one of the directors would visit them with a “turned down” Deprox unit and an H2O2 meter, and demonstrate that the levels were within the safety limit.

In February 2017, Richard Marsh published “How to test your Deprox” This gave simple instructions to Deprox users whereby they could check the H2O2 concentration level that their machine was set to. This made Hygiene Solutions smoke and mirrors tactic rather risky – hence the recent decision to double the deactivation cycle time.

The conversation with a former Deprox operator reproduced below will give a taste of the utterly irresponsible attitude of the directors of the company.

Lying rick fentiman mark fentiman

And further…

Lying rick fentiman mark fentiman too.PNG